V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270016956 | 270010217 | 1.89 | 59 | Curative (C) | 2017-02-02 | 2017-02-28 | Irinotecan | N | N | 270018889 | IRINOTECAN |
| 270016957 | 270010221 | 1.57 | 73.8 | Palliative (P) | 2016-07-26 | 2016-09-06 | Carboplatin AUC 2 - 5 | N | N | 270018894 | CISPLATIN + GEMCITABINE |
| 270016960 | 270010225 | null | 85.72 | Adjuvant (A) | 2017-11-15 | 2017-11-23 | Panitumumab | N | N | 270018973 | PANITUMUMAB |
| 270016961 | 270010227 | 1.89 | null | Curative (C) | 2013-03-16 | 2013-03-23 | NIVOLUMAB | N | null | 270018983 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016962 | 270010228 | 1.85 | 58 | Palliative (P) | 2014-12-02 | 2014-12-02 | IGEV | N | N | 270019014 | AFLIBERCEPT + FU + IRINOTECAN |
| 270016963 | 270014779 | 1.66 | 75.3 | Adjuvant (A) | 2014-06-03 | 2014-07-03 | IVE | N | null | 270019099 | IVE |
| 270016964 | 270014780 | 1.72 | 67 | null | null | 2016-08-13 | Cisplatin | null | null | 270019172 | CETUXIMAB + OXALIPLATIN + MDG |
| 270016965 | 270014781 | 1.7 | 89 | Palliative (P) | null | 2014-12-29 | BENDAMUSTINE | N | null | 270019205 | BENDAMUSTINE |
| 270016966 | 270010237 | 1.78 | 65.9 | Curative (C) | 2016-01-09 | 2016-01-23 | Cisplatin 7 day | N | N | 270019244 | CISPLATIN |
| 270016967 | 270010238 | 1.59 | 44.3 | null | 2017-04-13 | 2017-06-29 | Gemcitabine + Methylprednisolone | N | N | 270019251 | CISPLATIN |
| 270016968 | 270010242 | null | 75.6 | Palliative (P) | 2018-05-04 | 2018-05-30 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | 270019312 | CISPLATIN + GEMCITABINE |
| 270016969 | 270010244 | 1.66 | 83.8 | null | 2014-06-22 | 2014-06-23 | Cetuximab + Oxaliplatin + MdG Load | 02 | N | 270019316 | ABVD R |
| 270016970 | 270010248 | 1.75 | 96.7 | Palliative (P) | 2014-02-19 | 2014-04-01 | Vinblastine weekly | 2 | null | 270019367 | CISPLATIN |
| 270016971 | 270010249 | 1.72 | null | Palliative (P) | 2013-07-31 | 2014-05-26 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | N | N | 270019375 | CISPLATIN + GEMCITABINE |
| 270016972 | 270014789 | 1.66 | 68.4 | Curative (C) | null | 2015-10-21 | Oxaliplatin + Raltitrexed | null | N | 270019385 | VINBLASTINE |
| 270016973 | 270010252 | 1.76 | 133.5 | Curative (C) | 2015-05-10 | 2015-05-13 | IGEV | N | N | 270019403 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016974 | 270010255 | 1.7 | null | Adjuvant (A) | 2015-04-23 | 2015-04-28 | IVE | N | N | 270019416 | IVE |
| 270016975 | 270010258 | 0 | 56.6 | Palliative (P) | 2013-03-16 | 2013-11-20 | BEAM + Alemtuzumab Allo SCT | N | N | 270019421 | AFLIBERCEPT + FU + IRINOTECAN |
| 270016976 | 270010261 | 1.8 | 64.3 | null | 2017-12-27 | 2018-01-03 | IVE | N | null | 270019450 | IVE |
| 270016977 | 270010263 | 1.7 | 64.45 | Palliative (P) | 2014-01-22 | 2014-10-01 | NIVOLUMAB | N | N | 270019489 | BEVACIZUMAB |
| 270016978 | 270018505 | 1.84 | 93.4 | Curative (C) | 2017-09-08 | 2017-09-19 | Vinblastine | 02 | Y | 270019557 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016979 | 270010267 | 1.74 | 70.8 | null | 2014-12-26 | 2014-12-29 | VEPEMB | N | N | 270019599 | CISPLATIN |
| 270016980 | 270014795 | 1.8 | 69.8 | Palliative (P) | null | 2014-10-15 | Bevacizumab 5mg/kg | N | N | 270019601 | CISPLATIN |
| 270016981 | 270010276 | 1.94 | null | Palliative (P) | 2015-10-18 | 2015-10-18 | IGEV | N | N | 270019620 | NIVOLUMAB |
| 270016982 | 270010279 | 1.58 | null | Palliative (P) | null | 2014-01-26 | Cisplatin | N | null | 270019669 | BEAM + ALEMTUZUMAB |
| 270016983 | 270010281 | 1.49 | null | Curative (C) | 2018-05-15 | 2018-05-16 | Vinblastine | 2 | null | 270019704 | GEMCITABINE |
| 270016984 | 270010282 | 1.83 | null | null | 2014-12-10 | 2015-01-11 | IVE | N | N | 270019709 | IVE |
| 270016985 | 270010283 | 1.6 | 56.5 | Curative (C) | 2017-03-22 | 2017-03-29 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 270019712 | VEPEMB |
| 270016986 | 270010284 | 1.82 | 90.7 | Curative (C) | 2017-11-06 | 2017-11-22 | BEAM + Alemtuzumab Allo SCT | N | N | 270019714 | NIVOLUMAB |
| 270016987 | 270010285 | 0 | 69 | Disease modification (D) | null | 2017-11-09 | GDP | 01 | Y | 270019718 | GDP |
| 270016988 | 270010288 | 1.73 | 90.8 | Curative (C) | 2015-09-03 | 2015-09-05 | R ABVD | 2 | N | 270019721 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270016989 | 270010290 | 1.9 | 80.3 | Not known (9) | 2016-12-08 | 2016-12-08 | Cisplatin | 2 | N | 270019742 | BEVACIZUMAB |
| 270016990 | 270010292 | 1.76 | 101 | Curative (C) | 2014-05-27 | 2014-08-12 | IVE | N | N | 270019757 | IVE |
| 270016991 | 270010294 | 1.61 | 75.4 | Curative (C) | 2015-09-06 | 2016-03-21 | GEMCITABINE | N | N | 270019813 | VINBLASTINE |
| 270016992 | 270010295 | 1.67 | 64.7 | Palliative (P) | 2019-04-02 | 2019-04-02 | Vinblastine | N | N | 270019813 | AFLIBERCEPT + FU + IRINOTECAN |
| 270016993 | 270010296 | 1.82 | 56 | Curative (C) | 2015-12-12 | 2016-01-10 | Gemcitabine weekly | 2 | N | 270019823 | CISPLATIN |
| 270016994 | 270018508 | 1.76 | 96.2 | Curative (C) | 2013-10-14 | 2013-12-18 | BEAM + Alemtuzumab Allo SCT | N | N | 270019825 | BEAM + ALEMTUZUMAB |
| 270016995 | 270010298 | 1.81 | null | Curative (C) | 2015-03-19 | 2015-03-20 | R ABVD | N | null | 270019882 | AFLIBERCEPT + FU + IRINOTECAN |
| 270016996 | 270010298 | 1.76 | 83.9 | Curative (C) | 2017-05-15 | 2017-05-15 | IGEV | N | N | 270019882 | GEMCITABINE |
| 270016997 | 270010301 | null | 57 | Palliative (P) | 2016-04-27 | 2016-04-27 | Panitumumab | 2 | N | 270019886 | VINBLASTINE |
| 270016998 | 270010303 | 1.78 | 85.6 | null | 2018-12-08 | 2018-12-29 | BEAM + Alemtuzumab Allo SCT | N | null | 270019907 | CISPLATIN |
| 270016999 | 270010306 | 1.72 | null | Curative (C) | 2017-09-03 | 2017-09-03 | Cyclophosphamide High Dose | 02 | N | 270019915 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270017000 | 270010309 | 1.56 | 59 | Curative (C) | 2014-08-04 | 2014-08-25 | Irinotecan 14day | N | N | 270019941 | IRINOTECAN |
| 270017001 | 270010309 | 1.55 | 79.6 | Curative (C) | 2016-11-16 | 2016-11-17 | Cyclophosphamide High Dose | 02 | N | 270019941 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270017002 | 270010309 | 1.65 | 58 | Curative (C) | 2013-06-15 | 2013-06-28 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | N | 270019941 | OXALIPLATIN + RALTITREXED |
| 270017003 | 270017169 | 1.88 | 82.1 | Adjuvant (A) | 2017-01-21 | 2017-01-21 | GDP | 2 | N | 270019948 | GDP |
| 270017004 | 270010313 | 1.72 | null | Curative (C) | 2015-11-10 | 2015-11-17 | IVE | 02 | null | 270019958 | IVE |
| 270017005 | 270010314 | 1.58 | 69.5 | Curative (C) | 2013-10-03 | 2013-10-07 | R ABVD | N | N | 270019972 | PANITUMUMAB |
| 270017006 | 270010317 | 1.68 | 51.5 | Neo-adjuvant (N) | 2016-09-03 | 2016-09-03 | Irinotecan | null | Y | 270019974 | IRINOTECAN |
| 270017007 | 270017171 | 1.8 | 65.6 | Neo-adjuvant (N) | 2016-11-04 | 2016-11-04 | Panitumumab | 02 | N | 270019980 | CETUXIMAB + OXALIPLATIN + MDG |